Ahmet Bılıcı

3.8k total citations
173 papers, 1.9k citations indexed

About

Ahmet Bılıcı is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ahmet Bılıcı has authored 173 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 78 papers in Pulmonary and Respiratory Medicine and 48 papers in Surgery. Recurrent topics in Ahmet Bılıcı's work include Gastric Cancer Management and Outcomes (32 papers), Metastasis and carcinoma case studies (19 papers) and Cancer Diagnosis and Treatment (14 papers). Ahmet Bılıcı is often cited by papers focused on Gastric Cancer Management and Outcomes (32 papers), Metastasis and carcinoma case studies (19 papers) and Cancer Diagnosis and Treatment (14 papers). Ahmet Bılıcı collaborates with scholars based in Türkiye, United Kingdom and United States. Ahmet Bılıcı's co-authors include Bala Başak Öven Ustaalıoğlu, Mesut Şeker, Mahmut Gümüş, Taflan Salepçi, Mehmet Aliustaoğlu, Umut Kefeli, Fatih Selçukbırıcık, Emre Yıldırım, Dilek Yavuzer and Hande Turna and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Orthopaedics and Related Research.

In The Last Decade

Ahmet Bılıcı

154 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmet Bılıcı Türkiye 21 853 655 597 297 284 173 1.9k
Narihide Goseki Japan 17 1.0k 1.2× 792 1.2× 1.0k 1.7× 282 0.9× 278 1.0× 80 2.6k
Jan‐Sing Hsieh Taiwan 25 912 1.1× 697 1.1× 740 1.2× 375 1.3× 93 0.3× 79 2.0k
Judith de Vos‐Geelen Netherlands 24 1.0k 1.2× 624 1.0× 612 1.0× 240 0.8× 232 0.8× 115 1.7k
Hubert Zirngibl Germany 31 1.1k 1.3× 754 1.2× 1.5k 2.5× 230 0.8× 219 0.8× 133 3.6k
Nurullah Zengin Türkiye 21 787 0.9× 479 0.7× 300 0.5× 175 0.6× 182 0.6× 160 1.5k
James L. Weese United States 26 1.3k 1.5× 580 0.9× 936 1.6× 407 1.4× 457 1.6× 94 2.4k
Ingvar Syk Sweden 29 1.3k 1.5× 684 1.0× 1.2k 2.1× 219 0.7× 151 0.5× 86 2.6k
Oscar Bertetto Italy 26 1.2k 1.4× 639 1.0× 561 0.9× 207 0.7× 207 0.7× 105 2.3k
Giles F. Whalen United States 27 1.4k 1.6× 573 0.9× 1.1k 1.9× 281 0.9× 463 1.6× 73 2.6k
John B. Ammori United States 22 681 0.8× 466 0.7× 754 1.3× 220 0.7× 243 0.9× 134 1.8k

Countries citing papers authored by Ahmet Bılıcı

Since Specialization
Citations

This map shows the geographic impact of Ahmet Bılıcı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Bılıcı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Bılıcı more than expected).

Fields of papers citing papers by Ahmet Bılıcı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmet Bılıcı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Bılıcı. The network helps show where Ahmet Bılıcı may publish in the future.

Co-authorship network of co-authors of Ahmet Bılıcı

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmet Bılıcı. A scholar is included among the top collaborators of Ahmet Bılıcı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmet Bılıcı. Ahmet Bılıcı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Helvacı, Kaan, et al.. (2025). Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis. Medicina. 61(1). 123–123. 3 indexed citations
2.
3.
Bılıcı, Ahmet, Özcan Yıldız, Saadettin Kılıçkap, et al.. (2025). Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina. 61(4). 638–638. 1 indexed citations
4.
Selçukbırıcık, Fatih, et al.. (2025). Late-Onset Myocarditis Following Immune Checkpoint Inhibitors Therapy: A Case Series with Literature Review. Medicina. 61(2). 302–302. 1 indexed citations
5.
Dane, Faysal, Erdem Göker, Kazım Uygun, et al.. (2025). Regional and Gender-Based Distribution of KRAS Mutations in Metastatic Colorectal Cancer Patients in Turkey: An Observational Study. Medicina. 61(4). 694–694.
6.
Bılıcı, Ahmet, et al.. (2024). Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes. Journal of Chemotherapy. 37(1). 60–68. 1 indexed citations
7.
Bılıcı, Ahmet, et al.. (2024). Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer. Current Problems in Cancer. 50. 101102–101102. 2 indexed citations
8.
Bılıcı, Ahmet, et al.. (2023). Impact of SPARC expression on treatment response of pembrolizumab and brain metastasis in patients with metastatic non-small cell lung cancer. International Immunopharmacology. 124(Pt B). 110947–110947. 3 indexed citations
9.
10.
Bılıcı, Ahmet, et al.. (2023). The Optimal Treatment Approaches and Prognostic Factors In Elderly Patients with Advanced Stage Biliary Tract Tumors. Acta Oncologica Turcica. 56(1). 81–89. 1 indexed citations
11.
Bılıcı, Ahmet, et al.. (2022). Coexistence of Primary Hyperparathyroidism and Differentiated Thyroid Carcinoma: Is It a Coincidence?. SHILAP Revista de lepidopterología. 26(3). 120–124. 1 indexed citations
12.
Şeker, Mesut, Ahmet Bılıcı, Huri Bulut, et al.. (2018). Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Oncology Research and Treatment. 41(9). 545–549. 4 indexed citations
13.
Bılıcı, Ahmet, et al.. (2017). Economic Burden of Gastric Cancer in Turkey. Value in Health. 20(9). A429–A429. 1 indexed citations
14.
Gümüş, Mahmut, Ahmet Bılıcı, Hatice Odabaş, et al.. (2016). Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors. World Journal of Urology. 35(7). 1103–1110. 8 indexed citations
15.
Bılıcı, Ahmet. (2015). Cytokeratin 18 for chemotherapy efficacy in gastric cancer. 4(3). 200–206. 3 indexed citations
16.
Bılıcı, Ahmet. (2014). Treatment options in patients with metastatic gastric cancer: Current status and future perspectives. World Journal of Gastroenterology. 20(14). 3905–3905. 75 indexed citations
17.
Bılıcı, Ahmet, et al.. (2013). Histerektomi materyallerinde histopatolojik tanıların incelenmesi. DergiPark (Istanbul University). 2(2). 91–94.
18.
Ustaalıoğlu, Bala Başak Öven, Ahmet Bılıcı, Asuman Orçun, et al.. (2012). Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls. Clinical & Translational Oncology. 14(5). 356–361. 17 indexed citations
19.
Döventaş, Alper, et al.. (2012). Prognostic significance of CD44 and c-erb-B2 protein overexpression in patients with gastric cancer.. PubMed. 59(119). 2196–201. 17 indexed citations
20.
Bılıcı, Ahmet, Faysal Dane, Mesut Şeker, et al.. (2011). Is Subdivision of pT2 Tumors Superior to Lymph Node Metastasis for Predicting Survival of Patients with Gastric Cancer? Review of 224 Patients from Four Centers. Digestive Diseases and Sciences. 56(11). 3226–3234. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Narihide Goseki Breakdown of academic impact, for papers by Jan‐Sing Hsieh Breakdown of academic impact, for papers by Judith de Vos‐Geelen Breakdown of academic impact, for papers by Hubert Zirngibl Breakdown of academic impact, for papers by Nurullah Zengin Breakdown of academic impact, for papers by James L. Weese Breakdown of academic impact, for papers by Ingvar Syk Breakdown of academic impact, for papers by Oscar Bertetto Breakdown of academic impact, for papers by Giles F. Whalen Breakdown of academic impact, for papers by John B. Ammori
Rankless by CCL
2026